Skin Channel
Related Channels

Common Reactions to Acitretin

Common Side Effects

Acitretin has been studied thoroughly in clinical trials. In these studies, the side effects that occurred were carefully documented.
In these studies, some of the most common acitretin side effects included:
  • Dry, chapped, irritated lips -- in over 75 percent of people
  • High triglycerides -- up to 66 percent
  • Hair loss -- in 50 to 75 percent
  • Peeling skin -- in 50 to 75 percent
  • Decreased HDL cholesterol ("good cholesterol") -- up to 40 percent
  • High cholesterol -- up to 33 percent
  • Runny or stuffy nose -- in 25 to 50 percent
  • Dry skin -- in 25 to 50 percent
  • Nail problems -- in 25 to 50 percent
  • Itching -- in 25 5o 50 percent.
Other common side effects (occurring in 10 to 25 percent of people) included:
  • Chills or shivering
  • Dry eyes
  • Dry mouth
  • Nosebleeds
  • Joint pain
  • Excessive growth of spinal bones
  • A red rash
  • Unusual sensations, such as tingling
  • Overly sensitive senses
  • Skin infections around the nails
  • Weakening of the skin
  • Sticky skin.

Final Thoughts

It is possible that you may experience some or none of the acitretin side effects listed in this article. Unfortunately, there is no way for your healthcare provider to know beforehand if you will have side effects from a medicine that you have never tried.
Therefore, make sure to let your healthcare provider know if you develop any side effects while taking this product or if you experience something that "just does not seem right." While it may not be a side effect, your healthcare provider will be able to diagnose and treat the problem.

Acitretin Drug Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2018 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.